Is sorafenib plus interferon α2b safe and effective in patents with renal cell carcinoma?

被引：4
|
作者：
Rini, Brian I. [1 ]
机构：
[1] Cleveland Clin, Dept Solid Tumor Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2008年 / 5卷 / 03期
关键词：
combination; efficacy; interferon alpha; renal cell carcinoma; sorafenib;
D O I：
10.1038/ncpuro1036
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [31] Renal failure after treatment with interferon alpha 2b
    Roeloffzen, WWH
    Hospers, GAP
    De Vries, EGE
    Navis, GJ
    ANTICANCER RESEARCH, 2002, 22 (03) : 1929 - 1931
  • [32] Phase II clinical trial of sorafenib plus interferon-alfa treatment for patients with metastatic renal cell carcinoma in Japan
    Eto, M.
    Wada, Y.
    Hirao, Y.
    Mita, K.
    Arai, Y.
    Kimura, G.
    Shinohara, N.
    Hinotsu, S.
    Tatsugami, K.
    Naito, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S673 - S673
  • [33] Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
    Eto, Masatoshi
    Kawano, Yoshiaki
    Hirao, Yoshihiko
    Mita, Koji
    Arai, Yoichi
    Tsukamoto, Taiji
    Hashine, Katsuyoshi
    Matsubara, Akio
    Fujioka, Tomoaki
    Kimura, Go
    Shinohara, Nobuo
    Tatsugami, Katsunori
    Hinotsu, Shiro
    Naito, Seiji
    BMC CANCER, 2015, 15
  • [34] Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
    Masatoshi Eto
    Yoshiaki Kawano
    Yoshihiko Hirao
    Koji Mita
    Yoichi Arai
    Taiji Tsukamoto
    Katsuyoshi Hashine
    Akio Matsubara
    Tomoaki Fujioka
    Go Kimura
    Nobuo Shinohara
    Katsunori Tatsugami
    Shiro Hinotsu
    Seiji Naito
    BMC Cancer, 15
  • [35] Effects of Pegylated Interferon α2b on Metastasis of Hepatocellular Carcinoma
    Arakawa, Yusuke
    Shimada, Mitsuo
    Utsunomiya, Tohru
    Imura, Satoru
    Morine, Yuji
    Ikemoto, Tetsuya
    JOURNAL OF SURGICAL RESEARCH, 2012, 172 (01) : 95 - 101
  • [36] Safe and Effective Delivery of Amphotericin B: A Survey of Patents
    Kaur, Lakhvir
    Abhijeet
    Jain, Subheet K.
    RECENT PATENTS ON NANOTECHNOLOGY, 2017, 11 (03) : 214 - 234
  • [37] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [38] MECHANISTIC ANALYSIS OF SYNERGISTIC ANTITUMOR EFFECTS OF INTERFERON-α AND SORAFENIB IN RENAL CELL CARCINOMA
    Eto, Masatoshi
    Takeuchi, Ario
    Kamiryo, Yoriyuki
    Tatsugami, Katsunori
    Naito, Seii
    JOURNAL OF UROLOGY, 2009, 181 (04): : 154 - 154
  • [39] Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-α on Treatment of Renal Cell Carcinoma
    Takeuchi, Ario
    Eto, Masatoshi
    Tatsugami, Katsunori
    Yamada, Hisakata
    Oki, Toshihiro
    Kiyoshima, Keijiro
    Yoshikai, Yasunobu
    Naito, Seiji
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2549 - 2556
  • [40] Acute interstitial pneumonia caused by interleukin-2 and interferon α-2b therapy for renal cell carcinoma: a case report and clinical study
    Zhang Hanyu
    Xie Miaorong
    CHINESE MEDICAL JOURNAL, 2014, 127 (23) : 4154 - 4156
12345